Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Total Marrow Irradiation for Second Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia

Alida Dominietto, MD, Stefano Vagge, MD, Susanta Hui, PhD, Carmen Di Grazia, MD, Teresa Lamparelli, MD, Stefania Bregante, MD, Anna Maria Raiola, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Renzo Corvò, MD, Emanuele Angelucci, MD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-140669

Published: 2020

Journal Articles

Outcome of 673 Patients with Hematologic Malignancies Surviving at Least 8 YEARS Post- Allogeneic Transplants: Risk Factors and Quality of Life

Giuseppe Sapienza, MD, Teresa Lamparelli, Alida Dominietto, MD, Anna Maria Raiola, MD, Carmen Di Grazia, MD, Francesca Gualandi, Simona Sica, MD, Elisabetta Metafuni, Emanuele Angelucci, MD, Andrea Bacigalupo, MD

Blood (2019) 134 (Supplement_1): 4601.

https://doi.org/10.1182/blood-2019-131959

Published: 2019

Journal Articles

Full Donor Chimerism after Allografts for Myelofibrosis: The Role of Conditioning Regimen

Patrizia Chiusolo, Sabrina Giammarco, MD PhD, Teresa Lamparelli, Lucia Casarino, Monica Rossi, Alida Dominietto, MD, Anna Maria Raiola, MD, Francesca Gualandi, Carmen Di Grazia, MD, Silvia Betti, MD PhD, Federica Sorà, MD, Elena Rossi, MD PhD, Luciana Teofili, MD, Simona Sica, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2019) 134 (Supplement_1): 4490.

https://doi.org/10.1182/blood-2019-126711

Published: 2019

Journal Articles

The Impact of Aminoacid Substitution at Position 116 Class I HLA, in Unrelated Donor Transplants

Patrizia Chiusolo, Teresa Lamparelli, Giuseppe Sapienza, MD, Alida Dominietto, MD, Anna Maria Raiola, MD, Carmen Di Grazia, MD, Sabrina Giammarco, MD PhD, Francesca Gualandi, Elisabetta Metafuni, Monica Rossi, Gessica Minnella, Simona Sica, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2019) 134 (Supplement_1): 4620.

https://doi.org/10.1182/blood-2019-130614

Published: 2019

Journal Articles

Unmanipulated Haploidentical Marrow Transplantation with a Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen: An Update on 444 Patients

Andrea Bacigalupo, MD, Anna Maria Raiola, MD, Alida Dominietto, MD, Carmen Di Grazia, MD, Stefania Bregante, Francesca Gualandi, Maria Teresa Van Lint, MD, Patrizia Chiusolo, MD, Luca Laurenti, MD, Federica Sora, Sabrina Giammarco, MD PhD, Simona Sica, MD, Emanuele Angelucci, MD

Blood (2018) 132 (Supplement 1): 3351.

https://doi.org/10.1182/blood-2018-99-118850

Published: 2018

Journal Articles

Pre-Transplant Minimal Residual Disease Evaluation Performed By Molecular WT1-Based or Multicolor Flow Cytometry Assessment Overcomes the Prognostic Value of Cytogenetic and Molecular Risk Factors at Diagnosis in Advanced Acute Myeloid Leukemia Patients

Fabio Guolo, MD, Paola Minetto, MD, Marino Clavio, MD, Nicoletta Colombo, PhD, Annalisa Kunkl, MD, Enrico Carminati, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Filippo Ballerini, MD, Maurizio Miglino, PhD, Emanuele Angelucci, Roberto M Lemoli, MD, Marco Gobbi, MD

Blood (2017) 130 (Supplement 1): 3316.

https://doi.org/10.1182/blood.V130.Suppl_1.3316.3316

Published: 2017

Journal Articles

The Effect of Prolonged Graft Versus Myelofibrosis May Influence the Prognosis of Patients with Myelofibrosis Relapsing after Allogenic Hematopoietic Stem Cell Transplantation: A Single Center Experience

Daniele Avenoso, Stefania Bregante, Anna Maria Raiola, MD, Riccardo Varaldo, Francesca Gualandi, Alida Dominietto, MD, Giannoni Livia, Carlo Marani, Carmen Di Grazia, MD, Teresa Lamparelli, Maria Teresa van Lint, Emanuele Angelucci

Blood (2017) 130 (Supplement 1): 5539.

https://doi.org/10.1182/blood.V130.Suppl_1.5539.5539

Published: 2017

Journal Articles

Early Minimal Residual Disease Assessment after Acute Myeloid Leukemia Induction with Fludarabine Cytarabine and Idarubicin (FLAI) Provides the Most Useful Prognostic Information

Paola Minetto, MD, Fabio Guolo, MD, Marino Clavio, MD, Annalisa Kunkl, MD, Nicoletta Colombo, PhD, Enrico Carminati, Giuseppina Fugazza, Simona Matarese, MD, Daniela Guardo, MD, Filippo Ballerini, MD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Antonia Cagnetta, MD, Michele Cea, Maurizio Miglino, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD

Blood (2017) 130 (Supplement 1): 5047.

https://doi.org/10.1182/blood.V130.Suppl_1.5047.5047

Published: 2017

Journal Articles

Busulfan Fludarabine (BU-FLU) Compared to Thiotepa Busulfan Fludarabine (TBF) for Allogeneic Transplants in Acute Myeloid Leukemia (AML) or Refractory Anemia with Excess Blasts (RAEB) in Remission

Federica Sora, MD, Simona Sica, MD, Carmen Di Grazia, MD, Patrizia Chiusolo, Luca Laurenti, Nicola Mordini, Attilio Olivieri, Anna Paola Iori, Emanuele Angelucci, Andrea Bacigalupo, MD

Blood (2017) 130 (Supplement 1): 909.

https://doi.org/10.1182/blood.V130.Suppl_1.909.909

Published: 2017

Journal Articles

Minimal Residual Disease Assessment May Drive Post Remission Therapy in Acute Myeloid Leukemia. It's Time for MRD-Driven Therapy

Paola Minetto, MD, Fabio Guolo, MD, Marino Clavio, MD, Annalisa Kunkl, MD, Filippo Ballerini, MD, Nicoletta Colombo, PhD, Enrico Carminati, Giuseppina Fugazza, Giordana Pastori, MD, Simona Matarrese, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Andrea Bacigalupo, MD, Roberto Massimo Lemoli, MD, Maurizio Miglino, PhD, Marco Gobbi, MD

Blood (2016) 128 (22): 2895.

https://doi.org/10.1182/blood.V128.22.2895.2895

Published: 2016

Journal Articles

A Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen, Following Unmanipulated Haploidentical Bone Marrow Transplantation, for Acute Myeloid Leukemia: A Multicenter Study

Patrizia Chiusolo, MD, Gesine Bug, Attilio Olivieri, MD, Brune Mats, MD, Nicola Mordini, MD, Emilio Paolo Alessandrino, MD, Alida Dominietto, MD, Anna Maria Raiola, MD, Carmen Di Grazia, MD, Francesca Gualandi, MD, Maria Teresa van Lint, MD, Emanuele Angelucci, MD, Andrea Bacigalupo, MD

Blood (2016) 128 (22): 1234.

https://doi.org/10.1182/blood.V128.22.1234.1234

Published: 2016

Journal Articles

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Anna Maria Raiola, MD, Sara Aquino, MD, Germana Beltrami, MD, Stefania Bregante, MD, Fabio Cruciani, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Anna Ghiso, MD, Francesca Gualandi, MD, Adalberto Ibatici, MD, Teresa Lamparelli, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Riccardo Varaldo, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3173.

https://doi.org/10.1182/blood.V128.22.3173.3173

Published: 2016

Journal Articles

Androgens MAY BOOST Hematologic Response to ANTI-Thymocyte Globulin in Acquired Aplastic Anemia

Sabrina Giammarco, MD, Maria Teresa van Lint, MD, Teresa Lamparelli, MD, Francesca Gualandi, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Stefania Bregante, MD, Simona Sica, Andrea Bacigalupo, MD

Blood (2016) 128 (22): 3900.

https://doi.org/10.1182/blood.V128.22.3900.3900

Published: 2016

Journal Articles

Combining Flow Cytometry and Molecular Assessment Improves the Prognostic Value of Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia

Fabio Guolo, MD, Paola Minetto, MD, Federica Galaverna, MD, Daniela Guardo, MD, Nicoletta Colombo, PhD, Annalisa Kunkl, MD, Marino Clavio, MD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Filippo Ballerini, MD, Maurizio Miglino, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD

Blood (2016) 128 (22): 521.

https://doi.org/10.1182/blood.V128.22.521.521

Published: 2016

Journal Articles

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

Andrea Bacigalupo, MD, H. Joachim Deeg, MD, Dolores Caballero, MD PhD, Francesca Gualandi, MD, Anna Maria Raiola, MD, Riccardo Varaldo, MD, Carmen Di Grazia, MD, Lucia López Corral, PhD MD, Maria Teresa van Lint, MD

Blood (2016) 128 (22): 671.

https://doi.org/10.1182/blood.V128.22.671.671

Published: 2016

Journal Articles

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia

Fabio Guolo, MD, Federica Galaverna, MD, Paola Minetto, MD, Livia Giannoni, MD, Chiara Ghiggi, PhD, Marino Clavio, MD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Adalberto Ibatici, MD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 2029.

https://doi.org/10.1182/blood.V126.23.2029.2029

Published: 2015

Journal Articles

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Carmen Di Grazia, MD, Simona Geroldi, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Nicoletta Colombo, PhD, Elisabetta Tedone, Silvia Luchetti, Teresa Lamparelli, Francesca Gualandi, MD, Adalberto Ibatici, MD, Stefania Bregante, Maria Teresa van Lint, Anna Maria Raiola, Alida Dominietto, MD, Riccardo Varaldo, Federica Galaverna, Anna Ghiso, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 1866.

https://doi.org/10.1182/blood.V126.23.1866.1866

Published: 2015

Journal Articles

Natural Killer (NK) Alloreactivity Seems Not to Play a Role in Preventing Leukemia Relapse in Unmanipulated Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide

Federica Galaverna, MD, Fabio Guolo, MD, Daniela Pende, MD, Alida Dominietto, MD, Raffaella Meazza, PhD, Michela Falco, PhD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Anna Ghiso, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD, Paola Minetto, MD, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 2033.

https://doi.org/10.1182/blood.V126.23.2033.2033

Published: 2015

Journal Articles

Multidisciplinary Evaluation Improves Efficacy and Safety of Iron Chelation Therapy with Deferasirox in MDS Elderly Patients

Blood (2015) 126 (23): 4558.

https://doi.org/10.1182/blood.V126.23.4558.4558

Published: 2015

Journal Articles

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

Stefania Bregante, Alida Dominietto, MD, Anna Ghiso, Anna Maria Raiola, Francesca Gualandi, MD, Riccardo Varaldo, Carmen Di Grazia, MD, Teresa Lamparelli, Silvia Luchetti, Simona Geroldi, Lucia Casarino, Sarah Pozzi, Elisabetta Tedone, Maria Teresa van Lint, MD, Federica Galaverna, Gianni Barosi, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 4336.

https://doi.org/10.1182/blood.V126.23.4336.4336

Published: 2015

NARROW

Total Marrow Irradiation for Second Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia

Outcome of 673 Patients with Hematologic Malignancies Surviving at Least 8 YEARS Post- Allogeneic Transplants: Risk Factors and Quality of Life

Full Donor Chimerism after Allografts for Myelofibrosis: The Role of Conditioning Regimen

The Impact of Aminoacid Substitution at Position 116 Class I HLA, in Unrelated Donor Transplants

Unmanipulated Haploidentical Marrow Transplantation with a Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen: An Update on 444 Patients

Pre-Transplant Minimal Residual Disease Evaluation Performed By Molecular WT1-Based or Multicolor Flow Cytometry Assessment Overcomes the Prognostic Value of Cytogenetic and Molecular Risk Factors at Diagnosis in Advanced Acute Myeloid Leukemia Patients

The Effect of Prolonged Graft Versus Myelofibrosis May Influence the Prognosis of Patients with Myelofibrosis Relapsing after Allogenic Hematopoietic Stem Cell Transplantation: A Single Center Experience

Early Minimal Residual Disease Assessment after Acute Myeloid Leukemia Induction with Fludarabine Cytarabine and Idarubicin (FLAI) Provides the Most Useful Prognostic Information

Busulfan Fludarabine (BU-FLU) Compared to Thiotepa Busulfan Fludarabine (TBF) for Allogeneic Transplants in Acute Myeloid Leukemia (AML) or Refractory Anemia with Excess Blasts (RAEB) in Remission

Minimal Residual Disease Assessment May Drive Post Remission Therapy in Acute Myeloid Leukemia. It's Time for MRD-Driven Therapy

A Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen, Following Unmanipulated Haploidentical Bone Marrow Transplantation, for Acute Myeloid Leukemia: A Multicenter Study

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Androgens MAY BOOST Hematologic Response to ANTI-Thymocyte Globulin in Acquired Aplastic Anemia

Combining Flow Cytometry and Molecular Assessment Improves the Prognostic Value of Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Natural Killer (NK) Alloreactivity Seems Not to Play a Role in Preventing Leukemia Relapse in Unmanipulated Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide

Multidisciplinary Evaluation Improves Efficacy and Safety of Iron Chelation Therapy with Deferasirox in MDS Elderly Patients

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only